Home / Resource Library / Durable ibrutinib responses in relapsed/refractory marginal zone lymphoma: long-term follow-up and biomarker analysis

Durable ibrutinib responses in relapsed/refractory marginal zone lymphoma: long-term follow-up and biomarker analysis

Results of a study investigating ibrutinib for treatment of relapsed marginal zone lymphoma.